Table 7. Fatty acid intake assessed with weighed dietary record (WDR) for 12-days and food frequency questionnaire (FFQ).
(n=85) Fatty acid |
unit | Weighed dietary record (WDR) for 12-days | Food frequency questionnaire (FFQ) | % difference† | |||||||||
|
|
||||||||||||
Mean | ± | SD | Median | (25%, 75%)* | Mean | ± | SD | Median | (25%, 75%)* | ||||
TFA‡ | Crude | mg/day | 53.2 | ± | 12.0 | 52.6 | (45.7,61.0) | 29.6 | ± | 9.0 | 28.6 | (23.4,34.9) | -44 |
Energy adjusted | 53.2 | ± | 6.8 | 52.9 | (48.8,57.5) | 29.6 | ± | 5.2 | 29.8 | (26.3,32.8) | -44 | ||
| |||||||||||||
SFA§ | Crude | mg/day | 14.7 | ± | 4.0 | 14.4 | (11.8,17.2) | 9.5 | ± | 3.2 | 9.3 | (7.1,11.5) | -35 |
Energy adjusted | 14.7 | ± | 2.6 | 15.0 | (12.7,16.6) | 9.5 | ± | 2.0 | 9.5 | (8.3,10.9) | -35 | ||
| |||||||||||||
Myristic (14:0) | Crude | mg/day | 17.6 | ± | 4.4 | 17.0 | (14.2,20.7) | 8.9 | ± | 2.9 | 8.7 | (6.7,10.6) | -49 |
Energy adjusted | 17.6 | ± | 2.7 | 17.9 | (15.7,19.4) | 8.9 | ± | 1.8 | 9.1 | (7.5,9.9) | -49 | ||
| |||||||||||||
Palmitic (16:0) | Crude | mg/day | 13.2 | ± | 2.9 | 12.8 | (11.5,14.5) | 6.6 | ± | 2.0 | 6.2 | (5.4,7.5) | -50 |
Energy adjusted | 13.2 | ± | 2.0 | 13.1 | (12.2,14.1) | 6.6 | ± | 1.2 | 6.7 | (5.9,7.5) | -50 | ||
| |||||||||||||
Stearic (18:0) | Crude | mg/day | 1.2 | ± | 0.5 | 1.2 | (0.8,1.5) | 0.9 | ± | 0.4 | 0.9 | (0.7,1.1) | -26 |
Energy adjusted | 1.2 | ± | 0.4 | 1.2 | (1.0,1.4) | 0.9 | ± | 0.3 | 0.9 | (0.7,1.1) | -26 | ||
| |||||||||||||
MUFA|| | Crude | mg/day | 8.6 | ± | 2.1 | 8.3 | (7.0,9.8) | 5.4 | ± | 1.6 | 5.3 | (4.1,6.4) | -37 |
Energy adjusted | 8.6 | ± | 1.3 | 8.7 | (7.4,9.6) | 5.4 | ± | 1.0 | 5.3 | (4.8,6.1) | -37 | ||
| |||||||||||||
Palmitoleic (16:1) | Crude | mg/day | 1.0 | ± | 0.3 | 0.9 | (0.8,1.1) | 0.6 | ± | 0.2 | 0.6 | (0.4,0.7) | -41 |
Energy adjusted | 1.0 | ± | 0.2 | 1.0 | (0.8,1.1) | 0.6 | ± | 0.1 | 0.6 | (0.5,0.7) | -41 | ||
| |||||||||||||
Oleic (18:1) | Crude | mg/day | 3.3 | ± | 0.9 | 3.3 | (2.7,3.8) | 2.0 | ± | 0.7 | 2.0 | (1.5,2.4) | -41 |
Energy adjusted | 3.3 | ± | 0.6 | 3.4 | (2.9,3.7) | 2.0 | ± | 0.4 | 1.9 | (1.7,2.3) | -41 | ||
| |||||||||||||
PUFA¶ | Crude | mg/day | 15.4 | ± | 3.9 | 14.9 | (12.4,17.9) | 7.8 | ± | 2.5 | 7.6 | (6.0,9.2) | -49 |
Energy adjusted | 15.4 | ± | 2.5 | 15.6 | (13.6,17.0) | 7.8 | ± | 1.5 | 7.8 | (6.7,8.9) | -49 | ||
| |||||||||||||
n-3 PUFA | Crude | mg/day | 10.0 | ± | 2.2 | 9.7 | (8.6,10.9) | 5.0 | ± | 1.5 | 4.9 | (4.1,5.8) | -49 |
Energy adjusted | 10.0 | ± | 1.7 | 9.9 | (9.1,10.9) | 5.0 | ± | 0.9 | 5.1 | (4.5,5.7) | -49 | ||
| |||||||||||||
Linolenic (18:3n-3) | Crude | mg/day | 1.7 | ± | 0.5 | 1.6 | (1.4,1.9) | 0.7 | ± | 0.3 | 0.7 | (0.6,0.8) | -56 |
Energy adjusted | 1.7 | ± | 0.4 | 1.7 | (1.5,1.9) | 0.7 | ± | 0.2 | 0.8 | (0.6,0.9) | -56 | ||
| |||||||||||||
EPA** (20:5n-3) | Crude | mg/day | 0.03 | ± | 0.01 | 0.02 | (0.02,0.03) | 0.02 | ± | 0.01 | 0.02 | (0.01,0.02) | -34 |
Energy adjusted | 0.03 | ± | 0.01 | 0.02 | (0.02,0.03) | 0.02 | ± | 0.00 | 0.02 | (0.01,0.02) | -34 | ||
| |||||||||||||
DPA† † (22:5n-3) | Crude | mg/day | 0.2 | ± | 0.04 | 0.2 | (0.1,0.2) | 0.1 | ± | 0.04 | 0.1 | (0.1,0.1) | -40 |
Energy adjusted | 0.2 | ± | 0.03 | 0.2 | (0.1,0.2) | 0.1 | ± | 0.03 | 0.1 | (0.1,0.1) | -40 | ||
| |||||||||||||
DHA‡ ‡ (22:6n-3) | Crude | mg/day | 0.4 | ± | 0.2 | 0.4 | (0.2,0.5) | 0.2 | ± | 0.1 | 0.2 | (0.1,0.3) | -45 |
Energy adjusted | 0.4 | ± | 0.2 | 0.4 | (0.3,0.5) | 0.2 | ± | 0.1 | 0.2 | (0.1,0.3) | -45 | ||
| |||||||||||||
n-6 PUFA | Crude | mg/day | 0.1 | ± | 0.05 | 0.1 | (0.1,0.1) | 0.1 | ± | 0.03 | 0.1 | (0.03,0.1) | -43 |
Energy adjusted | 0.1 | ± | 0.04 | 0.1 | (0.1,0.1) | 0.1 | ± | 0.03 | 0.1 | (0.04,0.1) | -43 | ||
| |||||||||||||
Linoleic (18:2n-6) | Crude | mg/day | 0.7 | ± | 0.3 | 0.7 | (0.5,0.8) | 0.4 | ± | 0.2 | 0.3 | (0.2,0.5) | -45 |
Energy adjusted | 0.7 | ± | 0.3 | 0.7 | (0.6,0.9) | 0.4 | ± | 0.2 | 0.4 | (0.3,0.5) | -45 | ||
| |||||||||||||
Eicosatrienoic (20:3n-6) | Crude | mg/day | 2.8 | ± | 0.8 | 2.7 | (2.4,3.3) | 1.4 | ± | 0.5 | 1.3 | (1.0,1.7) | -51 |
Energy adjusted | 2.8 | ± | 0.6 | 2.9 | (2.5,3.3) | 1.4 | ± | 0.4 | 1.4 | (1.1,1.6) | -51 | ||
| |||||||||||||
Arachidonic (20:4n-6) | Crude | mg/day | 10.1 | ± | 2.3 | 9.9 | (8.8,11.1) | 5.2 | ± | 1.5 | 4.9 | (4.2,5.9) | -49 |
Energy adjusted | 10.1 | ± | 1.7 | 10.0 | (9.3,11.1) | 5.2 | ± | 0.9 | 5.2 | (4.6,5.9) | -49 | ||
| |||||||||||||
n-6/n-3 ratio | Crude | 3.7 | ± | 0.7 | 3.5 | (3.2,4.2) | 4.0 | ± | 1.0 | 3.8 | (3.2,4.7) | 7 | |
Energy adjusted | 3.7 | ± | 0.7 | 3.8 | (3.2,4.2) | 4.0 | ± | 1.0 | 4.1 | (3.2,4.7) | 7 |
* : 25 and 75 percentiles.
† : (FFQ mean-WDR mean)/WDR mean (%)
‡ : Total fatty acids.
§ : Saturated fatty acids.
|| : Mono unsaturated fatty acids.
¶ : Poly unsaturated fatty acids.
**: Eicosapentaenoic acid.
† † : Docosapentaenoic acids.
‡ ‡ : Docosahexaenoic acids.